Bartoo AC, Nelson MT, Mawe GM. ATP induces guinea pig gallbladder smooth muscle excitability via the P2Y4 receptor and COX-1 activity. Am J Physiol Gastrointest Liver Physiol 294: G1362-G1368, 2008. First published April 24, 2008 doi:10.1152/ajpgi.00043.2008The purpose of this study was to elucidate the mechanisms by which ATP increases guinea pig gallbladder smooth muscle (GBSM) excitability. We evaluated changes in membrane potential and action potential (AP) frequency in GBSM by use of intracellular recording. Application of ATP (100 M) caused membrane depolarization and a significant increase in AP frequency that were not sensitive to block by tetrodotoxin (0.5 M). The nonselective P2 antagonist, suramin (100 M), blocked the excitatory response, resulting in decreased AP frequency in the presence of ATP. The excitatory response to ATP was not altered by pyridoxal-phosphate-6-azophenyl-2,4-disulfonic acid (30 M), a nonselective P2X antagonist. UTP also caused membrane depolarization and increased AP frequency, with a similar dose-response relationship as ATP. RT-PCR demonstrated that the P2Y 4, but not P2Y2, receptor subtype is expressed in guinea pig gallbladder muscularis. ATP induced excitation was blocked by indomethacin (10 M) and the cyclooxygenase (COX)-1 inhibitor SC-560 (300 nM), but not the COX-2 inhibitor nimesulide (500 nM). These data suggest that ATP stimulates P2Y 4 receptors within the gallbladder muscularis and, in turn, stimulate prostanoid production via COX-1 leading to increased excitability of GBSM. biliary motility; cyclooxygenase; purinergic; P2Y; prostaglandins ATP IS AN ABUNDANT SIGNALING molecule throughout the central and enteric nervous systems, where it can act as a neurotransmitter or long-term signaling molecule. ATP has been implicated in the production of prostaglandins in different cell types. For example, stimulation of P2Y receptors increases prostaglandin production in Madin-Darby canine kidney cells (43), astrocytes (7, 8) , and airway epithelium (28). In rat aorta (17) and guinea pig uterine smooth muscle (2, 35), contractions in response to ATP application are a result of prostaglandin production. A similar mechanism may exist in the gallbladder. In the early 1980s ATP was shown to induce contractions of guinea pig gallbladder smooth muscle (19, 42) . This contractile response was inhibited by prior incubation with the nonselective cyclooxygenase enzyme (COX) inhibitor indomethacin, suggesting the contraction to ATP is mediated by prostanoid production (42). However, it is unknown whether ATP is acting on intrinsic gallbladder neurons or acting directly on the smooth muscle. Likewise, it is unclear the mechanism of actions of ATP in terms of receptor and COX subtype.
ATP IS AN ABUNDANT SIGNALING molecule throughout the central and enteric nervous systems, where it can act as a neurotransmitter or long-term signaling molecule. ATP has been implicated in the production of prostaglandins in different cell types. For example, stimulation of P2Y receptors increases prostaglandin production in Madin-Darby canine kidney cells (43) , astrocytes (7, 8) , and airway epithelium (28) . In rat aorta (17) and guinea pig uterine smooth muscle (2, 35) , contractions in response to ATP application are a result of prostaglandin production. A similar mechanism may exist in the gallbladder. In the early 1980s ATP was shown to induce contractions of guinea pig gallbladder smooth muscle (19, 42) . This contractile response was inhibited by prior incubation with the nonselective cyclooxygenase enzyme (COX) inhibitor indomethacin, suggesting the contraction to ATP is mediated by prostanoid production (42) . However, it is unknown whether ATP is acting on intrinsic gallbladder neurons or acting directly on the smooth muscle. Likewise, it is unclear the mechanism of actions of ATP in terms of receptor and COX subtype.
Prostaglandins are signaling molecules produced from arachidonic acid by COX (50) . In the gallbladder, prostaglandins and COX expression is increased in patients with cholecystitis (29, 37, 38) and in animal models of gallbladder inflammation (40, 44) . During gallbladder inflammation muscle contraction in response to excitatory agonists is greatly reduced (55) . Prostaglandins contract gallbladder smooth muscle (GBSM) by acting on receptors expressed within the muscle (12, 53) . Furthermore, prostaglandin-induced contractions are preserved during gallbladder inflammation and increase cytoprotective mechanisms within the GBSM (53, 55) . Consequently, prostaglandins inhibit the reduction in agonist-induced GBSM contractions due to reactive oxygen species that may occur during gallstone disease (53) . Therefore, it has been suggested that prostaglandins provide a protective role on GBSM function during gallbladder disease (31, 46, 53) .
Considering the importance of ATP as a signaling molecule and the role of prostaglandins in gallbladder disease, we sought to elucidate the mechanisms by which ATP induces GBSM excitation. Using intracellular recording, we demonstrate that ATP induces membrane depolarization and an increase in action potential (AP) frequency of GBSM. Furthermore, we provide pharmacological and RT-PCR data that suggest that ATP stimulates P2Y 4 receptors that are linked to COX-1, resulting in GBSM excitation, likely through prostanoid production.
MATERIALS AND METHODS
Animals and tissue preparation. Male adult guinea pigs (200 -350 g) were exsanguinated under isoflurane anesthesia, according to a protocol approved by the Institutional Animal Care and Use Committee of the University of Vermont. Gallbladders were removed and placed in an ice-cold Krebs solution (in mM: 121 NaCl, 5.9 KCl, 2.5 CaCl 2, 1.2 MgCl2, 25 NaHCO3, 1.2 NaH2PO4, and 8 glucose, pH 7.4).
Gallbladders were cut open from neck to base, washed to remove bile, and pinned stretched mucosa side up in a Sylgard-coated dish (Dow Corning, Midland, MI). The mucosal layers were teased off with sharp forceps under stereoscopic microscopic observation to prepare whole mounts of muscularis propria. Samples not immediately used were kept in ice-chilled Krebs buffer for 2-4 h.
Intracellular recording. For intracellular recording, the gallbladders were cut in half to produce preparations suitable for recording. Preparations were stretched pinned in a small recording chamber (ϳ2.5 ml volume) under constant superfusion with heated Krebs (35-37°C) containing the myosin light chain kinase inhibitor wortmannin (0.5 M). The recording chamber was placed onto a Nikon TMD inverted microscope (Nikon USA) fitted with a Hoffman filter, and muscle bundles were identified under a ϫ10 objective. Sharp glass microelectrodes (80 -200 M⍀) backfilled with 2 M KCl were used for GBSM impalements. Electrical activity and membrane potential were recorded with a negative-capacity compensation amplifier (Axoclamp 2A, Axon Instruments, Union City, CA) with bridge circuitry. Electrical activity was analyzed by use of PowerLab/4SP and Chart 5, v.5.01 software (AD Instruments, Colorado Springs, CO). To initiate spontaneous electrical activity tissue was equilibrated for a minimum of 15 min before impalements. After a 5-10 min basal recording period, experimental compounds were applied to preparations through the superfusion buffer throughout the recording time frame for a minimum of five min before application of ATP. All GBSM cells within a given bundle discharge APs simultaneously and at the same frequency (6); therefore, if an impalement was lost during recording a new cell was impaled within the same muscle bundle to allow for a more continuous timeframe of AP frequency.
Drugs. Adenosine-5-triphosphate (ATP), suramin, reactive blue 2, tetrodotoxin (TTX), pyridoxal-phosphate-6-azophenyl-2,4-disulfonic acid (PPADS), uridine-5Ј-triphosphate (UTP), and wortmannin were purchased from Sigma (St. Louis, MO). Indomethacin was obtained from Cayman Biochemicals (San Diego, CA). Wortmannin and indomethacin were dissolved in DMSO and TTX was dissolved in 0.1% acetic acid in dH 2O. All other drugs were dissolved in KREBS. Diluents alone had no effect on GBSM AP frequency.
RT-PCR. Gallbladder muscularis preparations were placed in RNAlater (Ambion; Austin, TX) and stored at Ϫ20°C for a minimum of 48 h. Tissue was disrupted and homogenized by rotor-pestle and RNA was isolated by use of RNEasy Micro Kit (Qiagen; Valencia, CA). After elution of RNA, samples were incubated with DNase I (Ambion) for 20 -30 min at 37°C to eliminate any traces of DNA. Complementary DNA (cDNA) was produced by use of reaction vials containing 1 g RNA, 1 M random decamers (Promega; Madison, WI), 1 mM dNTPs, RNase inhibitor (Promega), 1ϫ Moloney murine leukemia virus (MMLV) buffer, and MMLV reverse transcriptase (200 units, Promega). The following protocol was used to produce cDNA: 20°C 10 min, 37°C 90 min, 70°C 15 min. For positive controls, liver samples (Ͻ20 mg) were incubated 5-10 min in 50 mM NaOH at 97°C to extract genomic DNA.
P2Y primers for RT-PCR were designed from mouse mRNA sequences identical to rat and human sequences (P2Y2 forward 5Ј-TTTCAACGAGGACTTCAAGT, reverse 5Ј-GATGCAGGTGAG-GAAGAGGA, acc. no. NM_008773; P2Y4 forward 5Ј-GCTATG-CAGTTGTCTTTGTGC, reverse 5Ј-CAAGGTGTCTGACAATGCCA, acc. no. NM_020621). Reaction mixtures contained 1ϫ Taq polymerase buffer, 1 unit HotStrat Taq polymerase (USB; Cleveland, OH), 1 mM dNTPs, and 4 l cDNA and were incubated in a thermocycler initially for 2 min at 94°C to activate the polymerase. Amplification occurred from 35 cycles of the following protocol: 94°C for 30 s, 55°C 30 s, 68°C 75 s. All products were run on 2% agarose gels at 80 V for 35 min. Amplified products were visualized under UV light with ethidium bromide by using ChemiDoc XRS (Bio-Rad; Hercules, CA) and images were captured with Quantity One software (Bio-Rad). Images were processed via Photoshop (Adobe; San Jose, CA).
Data analysis. Resting membrane potential was determined as the difference between bath potential and the lowest cellular potential during the recording trace. APs were defined as a rapid spike followed by a plateau phase (58) , and frequency was calculated (as Hz) from a 1-min period at given time points during the recording. For the ATP and UTP dose-response curve, AP frequency was normalized to the basal frequency of the cell immediately prior to drug application. Statistical analysis (paired t-test, repeated-measures ANOVA, or oneway ANOVA with multiple comparisons vs. control) was performed by using Number Cruncher Statistical Systems (NCSS; Kaysville, UT) or MicrocalOrigin (Microcal Software; Northampton, MA). Data are expressed as means Ϯ SE, and the difference was considered statistically significant at P Ͻ 0.05. The n value represents number of tissue preparations from different animals.
RESULTS
GBSM had a resting membrane potential of Ϫ46.7 Ϯ 2.3 mV and discharged APs at a frequency of 0.34 Ϯ 0.04 Hz with average amplitude of 43.4 Ϯ 3.6 mV (n ϭ 13), consistent with our previous reports on spontaneous activity in GBSM (4, 6, 58).
ATP induces a delayed excitatory response via a nonneuronal mechanism. Application of ATP (100 M) caused a delayed (30 -60 s) excitatory response in GBSM (Fig. 1A) which was characterized by a 5.3 Ϯ 1.1 mV membrane depolarization (P ϭ 0.007) along with a significant increase in AP frequency (0.66 Ϯ 0.02 Hz ATP 1 min vs. 0.33 Ϯ 0.06 Hz basal; P Ͻ 0.001). This excitatory response was transient, lasting ϳ4 min (0.38 Ϯ 0.08 Hz ATP 4 min vs. 0.33 Ϯ 0.06 Hz basal; P ϭ 0.47). In some cases, AP frequency in the continued presence of ATP fell below the control levels (Fig. 1B) . In the presence of the Na ϩ channel blocker, TTX (0.5 M), the excitatory response to ATP persisted (0.64 Ϯ 0.09 TTXϩATP vs. 0.26 Ϯ 0.04 Hz TTX control; P ϭ 0.02; figure not shown) and was not significantly different from ATP alone (0.64 Ϯ 0.09 TTXϩATP vs. 0.66 Ϯ 0.02 Hz ATP; P Ͼ 0.05), indicating the actions of ATP on GBSM are via a nonneuronal mechanism.
Evidence of P2Y 4 receptor-mediated excitatory response. ATP is known to act on two different classes of P2 receptors, P2X and P2Y receptors. Therefore, experiments were conducted to determine which class of P2 receptor mediates the To test whether a P2Y receptor was involved in the excitatory response the pyrimidine nucleotide UTP was used. UTP is an agonist of specific subtypes of the P2Y receptor (10, 47) . Similar to ATP, application of UTP (100 M) to GBSM induced membrane depolarization (9.8 Ϯ 4.7 mV) and an increase in AP frequency (0.4 Ϯ 0.09 Hz basal vs. 0.66 Ϯ 0.06 Hz; P ϭ 0.03, n ϭ 5). Concentration effect curves for ATP (EC 50 31 M) and UTP (EC 50 62 M) indicate comparable potencies and efficacies for these agonists (Fig. 4) . Of the seven P2Y receptor subtypes known to exist, two match the present data of being sensitive to UTP and blocked by suramin: P2Y 2 and P2Y 4 (1, 9, 10). To determine which of these subtypes are expressed in guinea pig gallbladder muscularis, we used RT-PCR with specific primer pairs to determine which of the two subtypes is expressed in the gallbladder muscularis. Both P2Y 2 and P2Y 4 primer pairs amplified appropriate-sized fragments from genomic DNA (334 and 127 bp, respectively); however, using guinea pig gallbladder muscularis cDNA, amplification was only obtained by using P2Y 4 primers (Fig. 5) . This result was repeated three times from cDNA obtained from two animals. Mammalian P2Y 4 receptors are more sensitive to block by reactive blue 2 (RB2) compared with P2Y 2 receptors. Therefore, we determined the effect of RB2 (100 M) on ATP-induced excitation. In the presence of RB2, ATP-induced membrane hyperpolarization (10.8 Ϯ 2.2 mV) and spontaneous APs in two of three cells investigated were eliminated whereas AP frequency was dramatically reduced in the third cell (0.10 Ϯ 0.10 Hz RB2ϩATP vs. 0.68 Ϯ 0.13 Hz RB2 control; n ϭ 3). Membrane hyperpolarization was observed in all three cells. This block of the ATP-induced excitatory response by RB2 is consistent with our RT-PCR data, suggesting involvement of P2Y 4 receptors. (42) . In the present study, indomethacin similarly abolished the excitatory response to ATP (0.14 Ϯ 0.06 Hz indomethacinϩATP vs. 0.32 Ϯ 0.05 Hz indomethacin control; P ϭ 0.005). There are two types of COX enzymes that can be constitutively active in smooth muscle, COX-1 and COX-2 (39, 45) . In the presence of the COX-1 inhibitor, SC-560 (300 nM), application of ATP completely eliminated GBSM APs and induced membrane hyperpolarization (9.7 Ϯ 2.9 mV) in all preparations (n ϭ 3), indicating a complete block of the excitatory response (Fig. 6) . Conversely, the COX-2 inhibitor nimesulide did not alter the excitatory response (Fig. 7) . In the presence of nimesulide (500 nM), ATP caused membrane depolarization (8. 
COX-1 activity is necessary for the excitatory ATP response. Previous studies have shown that indomethacin blocks ATPinduced contractions of GBSM

DISCUSSION
Prior studies have shown that exogenous application of ATP induces GBSM contraction (19, 42) . The focus of this study was to elucidate the mechanisms by which ATP stimulates GBSM excitation by using intracellular recording. We demonstrate, consistent with contractile studies, that ATP induces excitation of the GBSM characterized by membrane depolarization and increased AP frequency. Both of these responses were inhibited by suramin (nonselective P2 antagonist), indomethacin (nonselective COX inhibitor), and SC-560 (COX-1 inhibitor) and mimicked by UTP (selective P2Y agonist), indicating that ATP binds P2Y receptors and, in turn, stimulates prostanoid production.
ATP is known to bind to two classes of P2 receptors: ionotropic P2X receptors and metabotropic P2Y receptors. Our data from experiments involving suramin, PPADS, and UTP support the conclusion that ATP in the guinea pig gallbladder muscularis stimulates P2Y receptors and not P2X receptors. Three rodent P2Y receptors are sensitive to UTP: P2Y 2 , P2Y 4 , and P2Y 6 (10, 11, 47) . However, P2Y 2 and P2Y 4 but not P2Y 6 are sensitive to suramin (1, 52) , suggesting that ATP is acting on P2Y 2 and/or P2Y 4 receptor subtypes in GBSM. Our RT-PCR data indicate that P2Y 4 , not P2Y 2 , receptors are expressed A: primers specific to P2Y2 amplified an appropriate size product (334 bp) from genomic DNA (gDNA) but not from gallbladder muscularis cDNA (GBm). Conversely, P2Y4 primers amplify appropriate products (127 bp) from both gDNA and GBm. No amplification was observed in samples lacking reverse transcriptase (-RT) for either primer pair. B: trace demonstrating that RB2 blocked the excitatory response to ATP resulting in membrane hyperpolarization and elimination of spontaneous APs. Resting membrane potential for this cell was Ϫ47.83 mV. within the guinea pig gallbladder muscularis, and our RB2 data suggest that the excitatory actions of ATP on GBSM are mediated by this receptor.
When expressed in oocytes, rat P2Y 4 receptors demonstrate weak antagonism to suramin compared with P2Y 2 receptors whereas P2Y 4 , compared with P2Y 2 , is more sensitive to block by RB2 (52) . However, suramin inhibited the ATP-induced excitatory response in the present study. Since ATP is causing both an excitatory and an inhibitory response in GBSM, the observed result of ATP application reflects a balance between these two actions. Even though we observe inhibition, we may not be completely blocking the excitatory actions of ATP. This is supported by incomplete elimination of APs and lack of membrane hyperpolarization in the presence of suramin compared with the dramatic inhibitory effects of ATP in the presence of RB2 and our COX-1 inhibitor, SC-560. Collectively, our pharmacological and RT-PCR data indicate that the excitatory effects of ATP in GBSM are mediated via activation of the P2Y 4 receptor.
Although not the focus of the present study, ATP also had inhibitory effects on GBSM activity in the presence of suramin, RB2, indomethacin, and the COX-1 inhibitor SC-560. The precise mechanism for this inhibition is unclear but it is likely not mediated by a P2 receptor since it occurred in the presence of suramin. One possibility is that ATP is hydrolyzed by ectonucleotidases to produce adenosine, which then acts on adenosine receptors. Adenosine has been shown to induce GBSM relaxation (42) , and adenosine receptors are tightly coupled to cAMP, which, in GBSM, decreases activity through opening of K ATP channels (34) .
Prostanoids are synthesized from arachidonic acid by the enzyme COX (50) . In the present study, inhibition of COX activity by indomethacin blocked the excitatory response elicited by ATP, suggesting that production of prostanoids is necessary for this response. The specific COX-1 inhibitor SC-560, but not the COX-2 inhibitor nimesulide, also blocked the excitatory response to ATP in the GBSM. Although both COX-1 and COX-2 may be constitutively active in smooth muscle (12, 27, 39) , our data suggest that COX-1 is responsible for the production of prostanoids in response to ATP. This is consistent with other studies demonstrating that ATP-induced contractions of the uterus (2, 35) and arterial smooth muscle (17, 24, 48) are mediated by prostaglandins via activation of P2Y receptors. In Madin-Darby canine kidney cells, P2Y receptor activation leads to activation of phospholipase A 2 (PLA 2 ) (43). PLA 2 then cleaves arachidonic acid from membrane phospholipids, leading to prostanoid production via COX. It is possible that prostanoids are produced in a similar mechanism after stimulation of G protein-coupled P2Y receptors in the gallbladder. This is supported by the decrease in prostanoid production in guinea pig GBSM after PLA 2 inhibition (12) and the increase in prostaglandin levels detected in the human gallbladder following PLA 2 stimulation (18) .
Prostanoids can induce contractions of GBSM via activation of G protein-coupled receptors (12, 53) . In guinea pig GBSM, COX-1 activity has been shown to affect thromboxane A 2 (TxA 2 ) levels but not prostaglandin E 2 levels (12). TxA 2 receptor stimulation can increase intracellular Ca 2ϩ levels within smooth muscle via extracellular Ca 2ϩ influx through voltage-dependent Ca 2ϩ channels (VDCC) and inositol 1,4,5-trisphosphate (IP 3 )-mediated Ca 2ϩ release from intracellular stores (13) . Increases in intracellular Ca 2ϩ through opening of VDCC or IP 3 -mediated store release could account for the observed membrane excitation of GBSM in response to ATP (6, 20, 33) . TxA 2 receptors can also activate protein kinase C (PKC) within smooth muscle (3) . PKC is known to regulate K ATP channels within smooth muscle, possibly by modulating cAMP levels, which influence K ATP activity (36) . Decreased K ATP activity could explain the observed membrane depolarization of GBSM in response to ATP. Although PKC has been shown to decrease K ATP activity in GBSM (34, 57) , K ATP channels in the gallbladder appear to be less sensitive to PKC regulation than those in other types of smooth muscle (16) . This limited sensitivity may explain the modest level of depolarization of GBSM that was observed in response to ATP. Further investigation is needed to identify prostanoid(s) that are produced and mediate excitation of GBSM in response to ATP.
Interstitial cells of Cajal (ICC) generate pacemaker currents that are responsible for spontaneous slow-wave activity of gastrointestinal smooth muscle (22, 49) . Our laboratory has previously demonstrated that ICC-like cells exist in the guinea pig gallbladder (25) . In that study, gap junction uncouplers eliminated spontaneous activity in gallbladder smooth muscle cells but not in ICC-like cells, suggesting spontaneous activity in GBSM originates from ICC-like cells. ICC in the mouse antrum express prostaglandin receptors, which, when stimulated, increase slow-wave activity (21) . Therefore, along with possible influence of membrane channels, prostanoids may alter pacemaker activity in GBSM, resulting in the observed increase in AP frequency after application of ATP. The physiological source of ATP in the gallbladder is unknown. It is possible that ATP functions as a neurotransmitter. Takahashi et al. (51) demonstrated an increase in ATP concentrations in response to nerve stimulation in the guinea pig gallbladder. Therefore, ATP may be released from nerves within the gallbladder to stimulate GBSM contraction. In the urinary bladder, ATP is released by the urothelium in response to stretch and distortion (15, 23, 26) . Inflammation may also induce ATP release from epithelial cells in the mucosa. Another possibility is that gallbladder mucosa releases ATP to maintain or increase spontaneous activity in GBSM. This is supported by the AP characteristics that we have observed in GBSM preparations containing mucosa vs. muscularis preparations devoid of mucosa (5) . Cholangiocytes of the liver release ATP to stimulate local P2Y receptors that regulate ion transport and fluid secretion (14, 32) . Nathanson et al. (41) demonstrated that the hydrophilic bile salt ursodeoxycholate (UDC) stimulates ATP release from cholangiocytes, resulting in increased ATP concentrations within bile. UDC is a therapy for gallstone disease and can prevent or reverse the adverse effects of hydrophobic bile salts on smooth muscle function (30, 54, 56) . It has been suggested that prostaglandins provide a protective role of smooth muscle function during gallstone disease (31, 46, 53) . It is possible that UDC mediates its protective role in vivo, at least in part, through increases in bile ATP that lead to production of prostanoids by P2Y 4 activation in GBSM. Stimulation of the P2Y 4 receptor and resulting prostanoid production in the gallbladder may provide a protective role of smooth muscle contractility during gallbladder disease.
In conclusion, ATP increases GBSM excitability through activation of the P2Y 4 receptor, which depends on COX-1 activity. Our results are consistent with the concept that activation of P2Y 4 receptors by ATP leads to activation of COX-1, which in turn increases the production of prostanoids that may alter the function of membrane channels and/or pacemaker activity within the gallbladder muscularis.
